SEARCH

SEARCH BY CITATION

References

  • 1
    Ettinger SJ, Feldman EC. Hyperadrenocorticism in dogs, In: Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. Philadelphia: WB Saunders Co; 2010.
  • 2
    Feldman EC, Nelson RW, Pedersen D. Canine hyperadrenocorticism (Cushing's syndrome), In: Canine and Feline Endocrinology and Reproduction. Philadelphia: Saunders; 2004.
  • 3
    Boswood A, Lamb CR, White RN. Aortic and iliac thrombosis in six dogs. J Small Anim Pract 2000; 41:109114.
  • 4
    Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999; 13:338345.
  • 5
    LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990; 197:13681372.
  • 6
    Nichols R. Complications and concurrent disease associated with canine hyperadrenocorticism. Vet Clin North Am Small Anim Pract 1997; 27:309320.
  • 7
    Ramsey CC, Burney DP, Macintire DK, et al. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996; 209:780785.
  • 8
    Burns MG, Kelly AB, Hornof WJ, et al. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981; 178:388393.
  • 9
    Scavelli TD, Peterson ME, Matthiesen DT. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984). J Am Vet Med Assoc 1986; 189:13601364.
  • 10
    Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34:389393.
  • 11
    Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217:15001504.
  • 12
    Marschner CB, Bjørnvad CR, Kristensen AT, et al. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet Scand 2010; 52:3842.
  • 13
    Epstein KL, Brainard BM, Lopes MAF, et al. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care 2009; 19(1):96101.
  • 14
    Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005; 15:916.
  • 15
    Benitah N, Feldman EC, Kass PH, et al. Evaluation of serum 17-hydroxyprogesterone concentration after administration of ACTH in dogs with hyperadrenocorticism. J Am Vet Med Assoc 2005; 227:10951101.
  • 16
    Hill KE, Scott-Moncrieff JCR, Koshko MA, et al. Secretion of sex hormones in dogs with adrenal dysfunction. J Am Vet Med Assoc 2005; 226:556561.
  • 17
    Durila M, Kalincik T, Pacakova Z, et al. Discard volume necessary for elimination of heparin flush effect on thromboelastography. Blood Coagul Fibrinolysis 2010; 21:192195.
  • 18
    Perrotta G, Roberts L, Glazier J, et al. Use of sodium citrate anticoagulant for routine hematology analysis on the CELL-DYN® 4000: an opportunity to enhance efficiency in the clinical laboratory. Lab. Hematol. 1998; 4:156162.
  • 19
    Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976; 193:10941100.
  • 20
    Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 2003; 101:44164422.
  • 21
    Sjoberg HE, Blomback M, Granberg PO. Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 1976; 199:9598.
  • 22
    Dal Bo Zanon R, Fornasiero L, Boscaro M, et al. Clotting changes in Cushing's syndrome: elevated factor VIII activity. Folia Haematol Int Mag Klin Morphol Blutforsch 1983; 110:268277.
  • 23
    La Brocca A, Terzolo M, Pia A, et al. Recurrent thromboembolism as a hallmark of Cushing's syndrome. J Endocrinol Invest 1997; 20:211214.
  • 24
    Casonato A, Pontara E, Boscaro M, et al. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 1999; 10:145151.
  • 25
    Small M, Lowe GD, Forbes CD, et al. Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf) 1983; 19:503511.
  • 26
    McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100:15761583.
  • 27
    Jacoby RC, Owings JT, Ortega T, et al. Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Arch Surg 2001; 136:10031007.
  • 28
    Ambrosi B, Sartorio A, Pizzocaro A, et al. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes 2000; 108:294298.
  • 29
    Feldman BF, Rasedee A, Feldman EC. Haemostatic abnormalities in canine Cushing's syndrome. Res Vet Sci 1986; 41:228230.
  • 30
    Dal Bo Zanon R, Fornasiero L, Boscaro M, et al. Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemost 1982; 47:116117.
  • 31
    Patrassi GM, Sartori MT, Viero ML, et al. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 1992; 3:789793.
  • 32
    Patrassi GM DBZR, Boscaro M, Martinelli S, et al. Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost 1985; 54:518520.
  • 33
    Feldman BF, Zinkl JG, Jain NC, et al. Essential thrombocythemia and reactive thrombocytosis, In: Schalm's Veterinary Hematology. Baltimore: Lippincott Williams and Wilkins; 2000.
  • 34
    Snyder LA NJA, Grindem CB. Thrombocytosis in dogs: a retrospective study. Vet Clin Path 2007; 36:311318.
  • 35
    McNulty SE, Sasso P, Vesci J, et al. Platelet concentrate effects on thromboelastography. J Cardiothorac Vasc Anesth 1997; 11:828830.
  • 36
    Ortega TM, Feldman EC, Nelson RW, et al. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1996; 209:17241729.
  • 37
    Goy-Thollot I, Pechereau D, Keroack S, et al. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs. J Small Anim Pract 2006; 43:489492.